Ken Fisher's position in Astrazeneca plc is currently worth $1.69B. That's 0.62% of their equity portfolio (46th largest holding). The first Astrazeneca plc trade was made in Q3 2015. Since then Ken Fisher bought shares 35 more times and sold shares on four occasions. The stake costed the investor $1.06B, netting the investor a gain of 60% so far.